Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

9.25
-0.3100-3.24%
Post-market: 9.330.0800+0.86%19:30 EDT
Volume:3.59M
Turnover:33.62M
Market Cap:1.69B
PE:-90.68
High:9.69
Open:9.52
Low:9.18
Close:9.56
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.59
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-173.25
PE(LYR):2,884.32

Loading ...

Deals of the Day-Mergers and Acquisitions

Reuters
·
Sep 30

Xeris Biopharma COO Kevin McCulloch Sells $250,000 in Common Shares

Reuters
·
Sep 30

Xeris Biopharma Rises on Report of Lundbeck Takeover Interest

Reuters
·
Sep 30

Lundbeck exploring acquisition of Xeris, Bloomberg reports

TIPRANKS
·
Sep 30

Lundbeck is Said to Express Interest in Buying Xeris Biopharma - Bloomberg News

THOMSON REUTERS
·
Sep 30

Market Chatter: Lundbeck Said to Explore Potential Xeris Biopharma Acquisition

MT Newswires Live
·
Sep 30

Xeris Biopharma tells Bloomberg ‘not for sale’

TIPRANKS
·
Sep 30

Lundbeck Said to Explore Potential Xeris Biopharma Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 30

H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Sep 22

Xeris Biopharma is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Xeris Biopharma price target raised to $16 from $12 at Leerink

TIPRANKS
·
Sep 10

Medmix Drug Delivery Unit Partners with Xeris on XP-8121 D-Flex Pen Injector Development

Reuters
·
Sep 10

Xeris Biopharma hosts webinar on XP-8121 development program

TIPRANKS
·
Sep 09

Xeris Targets Phase 3 Start for Once-Weekly Levothyroxine Candidate XP-8121 by Year-End

Reuters
·
Sep 09

Xeris Biopharma CFO Steven Pieper Disposes of 5,000 Shares Worth $42,500

Reuters
·
Sep 02

Xeris to Host XP-8121 Hypothyroidism Program Overview Webinar

Reuters
·
Aug 26

Xeris Biopharma price target raised to $12 from $9 at Barclays

TIPRANKS
·
Aug 20

Why Xeris Biopharma (XERS) Is Up 6.6% After Tighter 2026 Revenue Guidance And Wider Losses

Simply Wall St.
·
Aug 19

Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.
·
Aug 14